Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Five recommendations for using large-scale publicly available data to advance health among American Indian peoples: the Adolescent Brain and Cognitive Development (ABCD) StudySM as an illustrative case
    Published on 2022-11-15
    3 years ago
  • The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia
    Published on 2022-11-14
    3 years ago
  • In Memoriam Donald S. Robinson, MD
    Published on 2022-11-14
    3 years ago
  • Lithium rescues dendritic abnormalities in Ank3 deficiency models through the synergic effects of GSK3β and cyclic AMP signaling pathways
    Published on 2022-11-13
    3 years ago
  • Working memory processing deficit associated with a nonlinear response pattern of the anterior cingulate cortex in first-episode and drug-naïve schizophrenia
    Published on 2022-11-13
    3 years ago
  • The basolateral amygdala to lateral septum circuit is critical for regulating social novelty in mice
    Published on 2022-11-11
    3 years ago
  • Effects of early life stress and subsequent re-exposure to stress on neuronal activity in the lateral habenula
    Published on 2022-11-11
    3 years ago
« Previous 1 … 112 113 114 115 116 … 143 Next »
Journal of Psychopharmacology
  • Corrigendum to The Australian Drug Harms Ranking Study
    Published on 2019-10-02
    6 years ago
  • Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency
    Published on 2019-09-26
    6 years ago
  • Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
    Published on 2019-09-26
    6 years ago
  • Social cognition impairments in long-term opiate users in treatment
    Published on 2019-09-26
    6 years ago
  • Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia
    Published on 2019-09-26
    6 years ago
  • Acute stress in adolescence vs early adulthood following selective deletion of dysbindin-1A: Effects on anxiety, cognition and other schizophrenia-related phenotypes
    Published on 2019-09-26
    6 years ago
  • No evidence for the involvement of serotonin or the 5-HTTLPR genotype in intertemporal choice in a larger community sample
    Published on 2019-09-24
    6 years ago
« Previous 1 … 112 113 114 115 116 … 134 Next »
European Neuropsychopharmacology
  • A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder
    Published on 2021-01-03
    5 years ago
  • The “VIP-ADHD trial”: Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?
    Published on 2020-12-31
    5 years ago
  • Contents
    Published on 2020-12-30
    5 years ago
  • Editorial Board
    Published on 2020-12-30
    5 years ago
  • ECNP Calendar of Meetings
    Published on 2020-12-30
    5 years ago
  • Brain-immune crosstalk in the treatment of major depressive disorder
    Published on 2020-12-30
    5 years ago
  • Shaping therapeutic trajectories in mental health: Instructive vs. permissive causality
    Published on 2020-12-29
    5 years ago
« Previous 1 … 112 113 114 115 116 … 153 Next »

   Pharma Pub